Header Logo

Connection

BRYAN BURT to Humans

Back to Details
This is a "connection" page, showing publications BRYAN BURT has written about Humans.
BRYAN BURT
Connection Strength
1.301
Humans
  1. Ad-SGE-DKK3 Gene Therapy Overcomes Resistance to Immune Checkpoint Blockade in Pleural Mesothelioma. Clin Cancer Res. 2025 Jul 01; 31(13):2639-2654.
    View in: PubMed
    Score: 0.025
  2. Technical Aspects of Robotic First Rib Resection. Thorac Surg Clin. 2023 Aug; 33(3):265-271.
    View in: PubMed
    Score: 0.022
  3. Robotic First Rib Resection and Robotic Chest Wall Resection. Thorac Surg Clin. 2023 Feb; 33(1):71-79.
    View in: PubMed
    Score: 0.021
  4. A Phase II Window of Opportunity Study of Neoadjuvant PD-L1 versus PD-L1 plus CTLA-4 Blockade for Patients with Malignant Pleural Mesothelioma. Clin Cancer Res. 2023 02 01; 29(3):548-559.
    View in: PubMed
    Score: 0.021
  5. Therapeutic Targeting of Macrophage Plasticity Remodels the Tumor-Immune Microenvironment. Cancer Res. 2022 07 18; 82(14):2593-2609.
    View in: PubMed
    Score: 0.021
  6. Checkpoint blockade in unresectable pleural mesothelioma: Event horizon for multimodal therapy. J Thorac Cardiovasc Surg. 2023 01; 165(1):364-368.
    View in: PubMed
    Score: 0.020
  7. Digital Biomarkers for the Objective Assessment of Disability in Neurogenic Thoracic Outlet Syndrome. Sensors (Basel). 2021 Nov 10; 21(22).
    View in: PubMed
    Score: 0.020
  8. Commentary: Sponsoring scholarship: Mountains moved by the American Association for Thoracic Surgery. J Thorac Cardiovasc Surg. 2023 05; 165(5):1899-1900.
    View in: PubMed
    Score: 0.020
  9. Transthoracic Robotic First and Cervical Rib Resection for Thoracic Outlet Syndrome. Ann Surg. 2023 06 01; 277(6):e1215-e1216.
    View in: PubMed
    Score: 0.019
  10. Commentary: The structure of structural racism revealed by lung cancer screening. J Thorac Cardiovasc Surg. 2022 06; 163(6):1931-1932.
    View in: PubMed
    Score: 0.019
  11. Improvement of Disability in Neurogenic Thoracic Outlet Syndrome by Robotic First Rib Resection. Ann Thorac Surg. 2022 09; 114(3):919-925.
    View in: PubMed
    Score: 0.019
  12. At the Crossroad of Decision: "One-stop Shop" to Treat Multiple Ground-glass Opacities. Ann Thorac Surg. 2022 04; 113(4):1315-1316.
    View in: PubMed
    Score: 0.019
  13. A year in general thoracic surgery published in the Journal of Thoracic and Cardiovascular Surgery: 2020. J Thorac Cardiovasc Surg. 2021 Jul; 162(1):253-258.
    View in: PubMed
    Score: 0.019
  14. Minimally invasive esophagectomy: Direction of the art. J Thorac Cardiovasc Surg. 2021 Sep; 162(3):701-704.
    View in: PubMed
    Score: 0.019
  15. Diagnostic Laparoscopy Improves Staging of Malignant Pleural Mesothelioma With Routine Positron Emission Tomography Imaging. Ann Thorac Surg. 2021 11; 112(5):1568-1574.
    View in: PubMed
    Score: 0.018
  16. Prognostic Role of Programmed Cell Death 1 Ligand 1 in Resectable Pleural Mesothelioma. Ann Thorac Surg. 2021 11; 112(5):1575-1583.
    View in: PubMed
    Score: 0.018
  17. Commentary: Respiratory frailty: Sarcopenia in earnest. J Thorac Cardiovasc Surg. 2022 03; 163(3):788.
    View in: PubMed
    Score: 0.018
  18. Safety of robotic first rib resection for thoracic outlet syndrome. J Thorac Cardiovasc Surg. 2021 Oct; 162(4):1297-1305.e1.
    View in: PubMed
    Score: 0.018
  19. Transthoracic Robotic First Rib Resection: Technique Crystallized. Ann Thorac Surg. 2020 07; 110(1):e71-e73.
    View in: PubMed
    Score: 0.017
  20. Commentary: The A, C, G, and Ts of differentiating stage I and stage IV lung cancer. J Thorac Cardiovasc Surg. 2020 08; 160(2):e83-e84.
    View in: PubMed
    Score: 0.017
  21. Commentary: Focused attention on proactive identification of deep venous thrombosis after pleurectomy/decortication for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2020 10; 160(4):1075-1076.
    View in: PubMed
    Score: 0.017
  22. Preoperative prediction of unresectability in malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2020 06; 159(6):2512-2520.e1.
    View in: PubMed
    Score: 0.017
  23. Commentary: Usurping the king: A step toward planning a biological checkmate on non-small cell lung carcinoma. J Thorac Cardiovasc Surg. 2019 09; 158(3):922-923.
    View in: PubMed
    Score: 0.017
  24. A year at the forefront of general thoracic surgery. J Thorac Cardiovasc Surg. 2019 07; 158(1):248-251.
    View in: PubMed
    Score: 0.016
  25. Utilization of Minimally Invasive Thymectomy and Margin-Negative Resection for Early-Stage Thymoma. Ann Thorac Surg. 2019 08; 108(2):405-411.
    View in: PubMed
    Score: 0.016
  26. Povidone-iodine results in rapid killing of thymic epithelial tumour cells through cellular fixation?. Interact Cardiovasc Thorac Surg. 2019 03 01; 28(3):353-359.
    View in: PubMed
    Score: 0.016
  27. Commentary: Postoperative blood transplantation for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019 06; 157(6):2480-2481.
    View in: PubMed
    Score: 0.016
  28. To slay a dragon: Timing of chemotherapy in resectable pleural mesothelioma. J Thorac Cardiovasc Surg. 2019 02; 157(2):767-768.
    View in: PubMed
    Score: 0.016
  29. Approach to a Posterior Cervicomediastinal Ganglioneuroma. Ann Thorac Surg. 2019 May; 107(5):e349-e351.
    View in: PubMed
    Score: 0.016
  30. A thinner peel to peel: Pleural thickness is prognostic in mesothelioma. J Thorac Cardiovasc Surg. 2019 01; 157(1):414-415.
    View in: PubMed
    Score: 0.016
  31. Mutation Ensemble for Response to Programmed Cell Death 1 Inhibition in Thymic Carcinoma. J Thorac Oncol. 2018 08; 13(8):e150-e152.
    View in: PubMed
    Score: 0.016
  32. A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma. J Thorac Oncol. 2018 09; 13(9):1400-1409.
    View in: PubMed
    Score: 0.015
  33. Giant Mediastinal Liposarcoma: A Rare Yet Distinct Clinical Entity. Ann Thorac Surg. 2018 09; 106(3):e117-e119.
    View in: PubMed
    Score: 0.015
  34. Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma. JCI Insight. 2018 04 05; 3(7).
    View in: PubMed
    Score: 0.015
  35. Thoracic outlet syndrome for thoracic surgeons. J Thorac Cardiovasc Surg. 2018 09; 156(3):1318-1323.e1.
    View in: PubMed
    Score: 0.015
  36. Therapeutic R2 resection for pleural mesothelioma. J Thorac Cardiovasc Surg. 2018 06; 155(6):2734-2735.
    View in: PubMed
    Score: 0.015
  37. The importance of R0. J Thorac Cardiovasc Surg. 2018 01; 155(1):428-429.
    View in: PubMed
    Score: 0.015
  38. Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma. Ann Thorac Surg. 2017 Nov; 104(5):1679-1687.
    View in: PubMed
    Score: 0.015
  39. Programmed death ligand 1-associated antitumor immunity in early-stage non-small cell lung cancer: Expression of major histocompatibility complex I as a prerequisite. J Thorac Cardiovasc Surg. 2018 01; 155(1):393-394.
    View in: PubMed
    Score: 0.015
  40. Subspecialty certification in thoracic oncology: Toward your next diploma. J Thorac Cardiovasc Surg. 2017 10; 154(4):1393-1394.
    View in: PubMed
    Score: 0.015
  41. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer. Ann Surg. 2017 08; 266(2):297-304.
    View in: PubMed
    Score: 0.015
  42. Incompletely resected non-small cell lung cancer: Do we know how to handle a positive margin? J Thorac Cardiovasc Surg. 2017 08; 154(2):673-674.
    View in: PubMed
    Score: 0.014
  43. Genomic Analysis of Thymic Epithelial Tumors Identifies Novel Subtypes Associated with Distinct Clinical Features. Clin Cancer Res. 2017 Aug 15; 23(16):4855-4864.
    View in: PubMed
    Score: 0.014
  44. A Meta-Analysis of Postoperative Radiotherapy for Thymic Carcinoma. Ann Thorac Surg. 2017 May; 103(5):1668-1675.
    View in: PubMed
    Score: 0.014
  45. Overall Survival Following Thoracoscopic vs Open Lobectomy for Early-stage Non-small Cell Lung Cancer: A Meta-analysis. Semin Thorac Cardiovasc Surg. 2017 Spring; 29(1):104-112.
    View in: PubMed
    Score: 0.014
  46. Clarity and clairvoyance: Review and prediction of management guidelines for early stage lung cancer. J Thorac Cardiovasc Surg. 2017 06; 153(6):1563-1564.
    View in: PubMed
    Score: 0.014
  47. Thoracoscopic lobectomy for clinical N2 and N1 lung cancer: Innovation outpacing standard of care. J Thorac Cardiovasc Surg. 2017 04; 153(4):977-978.
    View in: PubMed
    Score: 0.014
  48. Radiography nomography: Utility of a calculator in rational preoperative decision making for subsolid pulmonary nodules. J Thorac Cardiovasc Surg. 2017 02; 153(2):460-461.
    View in: PubMed
    Score: 0.014
  49. Determinants of Complete Resection of Thymoma by Minimally Invasive and Open Thymectomy: Analysis of an International Registry. J Thorac Oncol. 2017 01; 12(1):129-136.
    View in: PubMed
    Score: 0.014
  50. Progression of EGFR-Mutant Lung Adenocarcinoma is Driven By Alveolar Macrophages. Clin Cancer Res. 2017 Feb 01; 23(3):778-788.
    View in: PubMed
    Score: 0.014
  51. The ascent of POEM: Double-tunnel per oral endoscopic re-myotomy. J Thorac Cardiovasc Surg. 2016 Jun; 151(6):e103-4.
    View in: PubMed
    Score: 0.013
  52. Invited Commentary. Ann Thorac Surg. 2015 Nov; 100(5):1874.
    View in: PubMed
    Score: 0.013
  53. The Prevention and Management of Air Leaks Following Pulmonary Resection. Thorac Surg Clin. 2015 Nov; 25(4):411-9.
    View in: PubMed
    Score: 0.013
  54. Surgery versus SABR for resectable non-small-cell lung cancer. Lancet Oncol. 2015 Aug; 16(8):e372.
    View in: PubMed
    Score: 0.013
  55. Influence of experience and the surgical learning curve on long-term patient outcomes in cardiac surgery. J Thorac Cardiovasc Surg. 2015 Nov; 150(5):1061-7, 1068.e1-3.
    View in: PubMed
    Score: 0.013
  56. Diameter of Solid Tumor Component Alone Should be Used to Establish T Stage in Lung Adenocarcinoma. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1318-23.
    View in: PubMed
    Score: 0.013
  57. CTLA4 blockade in patients with malignant mesothelioma. Lancet Respir Med. 2015 Apr; 3(4):261-3.
    View in: PubMed
    Score: 0.012
  58. A meta-analysis of induction therapy for advanced thymic epithelial tumors. Ann Thorac Surg. 2015; 99(5):1848-56.
    View in: PubMed
    Score: 0.012
  59. Long-Term Outcomes of Surgical and Nonsurgical Management of Stage IV Thymoma: A Population-Based Analysis of 282 Patients. Semin Thorac Cardiovasc Surg. 2015; 27(1):1-3.
    View in: PubMed
    Score: 0.012
  60. A meta-analysis of resected metachronous second non-small cell lung cancer. Ann Thorac Surg. 2015 Apr; 99(4):1470-8.
    View in: PubMed
    Score: 0.012
  61. Unicentric, multifocal Castleman disease of the mediastinum associated with cerebellitis. Ann Thorac Surg. 2015 Jan; 99(1):e7-9.
    View in: PubMed
    Score: 0.012
  62. Improved detection of stage I non-small cell lung cancer with a serum-based assay. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):735-6.
    View in: PubMed
    Score: 0.012
  63. A meta-analysis of surgical versus nonsurgical management of recurrent thymoma. Ann Thorac Surg. 2014 Aug; 98(2):748-55.
    View in: PubMed
    Score: 0.012
  64. Malignant pleural mesothelioma and the Society of Thoracic Surgeons Database: an analysis of surgical morbidity and mortality. J Thorac Cardiovasc Surg. 2014 Jul; 148(1):30-5.
    View in: PubMed
    Score: 0.012
  65. Thoracoscopic lobectomy is associated with acceptable morbidity and mortality in patients with predicted postoperative forced expiratory volume in 1 second or diffusing capacity for carbon monoxide less than 40% of normal. J Thorac Cardiovasc Surg. 2014 Jul; 148(1):19-28, dicussion 28-29.e1.
    View in: PubMed
    Score: 0.012
  66. Clinical indications and results after chest wall resection for recurrent mesothelioma. J Thorac Cardiovasc Surg. 2013 Dec; 146(6):1373-9; discussion 1379-80.
    View in: PubMed
    Score: 0.011
  67. Expression of interleukin-4 receptor alpha in human pleural mesothelioma is associated with poor survival and promotion of tumor inflammation. Clin Cancer Res. 2012 Mar 15; 18(6):1568-77.
    View in: PubMed
    Score: 0.010
  68. Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival. Ann Thorac Surg. 2011 Oct; 92(4):1202-7.
    View in: PubMed
    Score: 0.010
  69. Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma. Cancer. 2011 Nov 15; 117(22):5234-44.
    View in: PubMed
    Score: 0.009
  70. Clinical images. Classic presentation of a type II obturator hernia. Am J Surg. 2010 Jun; 199(6):e75-6.
    View in: PubMed
    Score: 0.009
  71. The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors. J Immunol. 2009 Aug 01; 183(3):1789-96.
    View in: PubMed
    Score: 0.008
  72. Circulating HLA-DR(+) natural killer cells have potent lytic ability and weak antigen-presenting cell function. Hum Immunol. 2008 Aug; 69(8):469-74.
    View in: PubMed
    Score: 0.008
  73. Meckel's hemoperitoneum: a rare case of Meckel's diverticulitis causing intraperitoneal hemorrhage. Dig Dis Sci. 2006 Sep; 51(9):1546-8.
    View in: PubMed
    Score: 0.007
  74. Exposure-inducible genes may contribute to missingness in RNAseq-based gene expression analyses. Sci Rep. 2025 Aug 22; 15(1):30889.
    View in: PubMed
    Score: 0.006
  75. Gene expression in tumor and adjacent normal tissues in lung adenocarcinoma subtypes. BMC Cancer. 2025 Jul 14; 25(1):1169.
    View in: PubMed
    Score: 0.006
  76. Initial patient characteristics of Thoracic Surgical Oncology Group 102: A multicenter prospective registry of active surveillance in patients with multiple ground-glass opacities. J Thorac Cardiovasc Surg. 2025 Apr; 169(4):1100-1107.
    View in: PubMed
    Score: 0.006
  77. Soluble mesothelin-related peptide as a prognosticator in pleural mesothelioma patients receiving checkpoint immunotherapy. J Thorac Cardiovasc Surg. 2025 Apr; 169(4):1082-1095.e4.
    View in: PubMed
    Score: 0.006
  78. The influence of the American Association for Thoracic Surgery on clinical trial development by cardiothoracic surgeons. J Thorac Cardiovasc Surg. 2025 May; 169(5):1409-1414.
    View in: PubMed
    Score: 0.006
  79. Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors. Cancer Cell. 2024 Jul 08; 42(7):1202-1216.e8.
    View in: PubMed
    Score: 0.006
  80. Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing. Cytotherapy. 2024 03; 26(3):266-275.
    View in: PubMed
    Score: 0.006
  81. Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors. Science. 2023 09 08; 381(6662):eabn4180.
    View in: PubMed
    Score: 0.006
  82. Regional spread of nonneurogenic tumors to the skull base via the facial nerve. Otol Neurotol. 2003 Mar; 24(2):326-33.
    View in: PubMed
    Score: 0.005
  83. Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy. J Thorac Cardiovasc Surg. 2023 05; 165(5):1722-1730.
    View in: PubMed
    Score: 0.005
  84. An audit of results of a no-drainage practice policy after hepatectomy. Am J Surg. 2002 Nov; 184(5):441-5.
    View in: PubMed
    Score: 0.005
  85. A combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma. Br J Cancer. 2022 11; 127(9):1691-1700.
    View in: PubMed
    Score: 0.005
  86. Clinical Understaging, Treatment Response, and Survival Among Esophageal Adenocarcinoma Patients. J Surg Res. 2022 11; 279:256-264.
    View in: PubMed
    Score: 0.005
  87. A lepidic gene signature predicts patient prognosis and sensitivity to immunotherapy in lung adenocarcinoma. Genome Med. 2022 01 12; 14(1):5.
    View in: PubMed
    Score: 0.005
  88. Demographic Landscape of Cardiothoracic Surgeons and Residents at United States Training Programs. Ann Thorac Surg. 2022 07; 114(1):108-114.
    View in: PubMed
    Score: 0.005
  89. Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft. JCI Insight. 2021 07 08; 6(13).
    View in: PubMed
    Score: 0.005
  90. Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling. Mol Cancer Ther. 2021 08; 20(8):1469-1480.
    View in: PubMed
    Score: 0.005
  91. Using positron emission tomography with [(18)F]FDG to predict tumor behavior in experimental colorectal cancer. Neoplasia. 2001 May-Jun; 3(3):189-95.
    View in: PubMed
    Score: 0.005
  92. Staging Concordance and Guideline-Concordant Treatment for Esophageal Adenocarcinoma. Ann Thorac Surg. 2022 Jan; 113(1):279-285.
    View in: PubMed
    Score: 0.005
  93. Left Pulmonary Artery Patch Augmentation for Lung Transplant in a Patient With Situs Inversus. Tex Heart Inst J. 2021 01 01; 48(1).
    View in: PubMed
    Score: 0.005
  94. Evaluation and treatment of thoracic outlet syndrome during the global pandemic due to SARS-CoV-2 and COVID-19. J Vasc Surg. 2020 09; 72(3):790-798.
    View in: PubMed
    Score: 0.004
  95. Reply to Waller et?al. Standardizing Surgical Treatment for Mesothelioma. J Thorac Oncol. 2020 05; 15(5):e75-e77.
    View in: PubMed
    Score: 0.004
  96. Transcriptome-based molecular subtyping of non-small cell lung cancer may predict response to immune checkpoint inhibitors. J Thorac Cardiovasc Surg. 2020 04; 159(4):1598-1610.e3.
    View in: PubMed
    Score: 0.004
  97. Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting. J Thorac Oncol. 2019 10; 14(10):1718-1731.
    View in: PubMed
    Score: 0.004
  98. A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce. J Thorac Oncol. 2019 08; 14(8):1343-1353.
    View in: PubMed
    Score: 0.004
  99. Commentary: Adjuvant intensity-modulated radiation therapy for malignant pleural mesothelioma: Suspension of intention. J Thorac Cardiovasc Surg. 2019 09; 158(3):932-933.
    View in: PubMed
    Score: 0.004
  100. Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2019 04; 157(4):1682-1693.e1.
    View in: PubMed
    Score: 0.004
  101. Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. J Thorac Oncol. 2018 11; 13(11):1655-1667.
    View in: PubMed
    Score: 0.004
  102. Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors. J Thorac Imaging. 2018 May; 33(3):176-183.
    View in: PubMed
    Score: 0.004
  103. IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer. Cancer Immunol Res. 2018 06; 6(6):645-657.
    View in: PubMed
    Score: 0.004
  104. Matrix metalloproteinase 12 promotes tumor propagation in the lung. J Thorac Cardiovasc Surg. 2018 05; 155(5):2164-2175.e1.
    View in: PubMed
    Score: 0.004
  105. Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database. J Thorac Oncol. 2018 03; 13(3):436-446.
    View in: PubMed
    Score: 0.004
  106. Akt and SHP-1 are DC-intrinsic checkpoints for tumor immunity. JCI Insight. 2016 11 03; 1(18):e89020.
    View in: PubMed
    Score: 0.003
  107. Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer. Gut. 2017 02; 66(2):215-225.
    View in: PubMed
    Score: 0.003
  108. Fetal Heart Rate Monitoring During Surgical Correction of Spontaneous Pneumothorax During Pregnancy: Lessons in In Utero Resuscitation. Obstet Gynecol. 2016 Jan; 127(1):136-138.
    View in: PubMed
    Score: 0.003
  109. Basic experiments of bioabsorbable materials in prevention of postoperative intrapleural adhesions following thoracotomy. Gen Thorac Cardiovasc Surg. 2016 Feb; 64(2):82-6.
    View in: PubMed
    Score: 0.003
  110. Management of Complications After Pneumonectomy. Thorac Surg Clin. 2015 Aug; 25(3):335-48.
    View in: PubMed
    Score: 0.003
  111. Pleurectomy and decortication for metastatic renal cell carcinoma. J Thorac Cardiovasc Surg. 2015 Jul; 150(1):e3-5.
    View in: PubMed
    Score: 0.003
  112. Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy. Semin Oncol. 2014 Feb; 41(1):40-56.
    View in: PubMed
    Score: 0.003
  113. A dominant adenocarcinoma with multifocal ground glass lesions does not behave as advanced disease. Ann Thorac Surg. 2013 Aug; 96(2):411-8.
    View in: PubMed
    Score: 0.003
  114. Spontaneous diaphragm rupture associated with vaginal delivery. Gen Thorac Cardiovasc Surg. 2013 Aug; 61(8):473-5.
    View in: PubMed
    Score: 0.003
  115. Robotic microsurgery: corneal transplantation. Br J Ophthalmol. 2009 Dec; 93(12):1672-5.
    View in: PubMed
    Score: 0.002
  116. Human liver dendritic cells promote T cell hyporesponsiveness. J Immunol. 2009 Feb 15; 182(4):1901-11.
    View in: PubMed
    Score: 0.002
  117. Recent chemotherapy reduces the sensitivity of [18F]fluorodeoxyglucose positron emission tomography in the detection of colorectal metastases. J Clin Oncol. 2005 Dec 01; 23(34):8713-6.
    View in: PubMed
    Score: 0.002
  118. Diameter of non-small cell lung cancer correlates with long-term survival: implications for T stage. Chest. 2005 Nov; 128(5):3255-60.
    View in: PubMed
    Score: 0.002
  119. Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207). FASEB J. 2004 Jun; 18(9):1001-3.
    View in: PubMed
    Score: 0.001
  120. Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus. J Virol. 2001 Aug; 75(15):7050-8.
    View in: PubMed
    Score: 0.001
  121. Effects of preexisting immunity on the response to herpes simplex-based oncolytic viral therapy. Hum Gene Ther. 2000 Dec 10; 11(18):2465-72.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.